Home » Author Archives: dale buss (page 6)

Author Archives: dale buss

dale buss
Dale Buss is a long-time contributor to Chief Executive, Forbes, The Wall Street Journal and other top-flight business publications. He lives in Michigan.

How Some Companies Are Battling the Skills Shortage

Several recently-released studies are underscoring the dire cost to U.S. manufacturers of the acute shortage of skilled workers. But at the same time, manufacturing CEOs and company owners continue to show innovation and resilience in tackling the problem and not allowing the worst outcomes for their businesses.

Read More »

Business Leaders Adapt to Obamacare by the Thousands

Despite its highly publicized rocky start, the Affordable Care Act gained some traction over the last couple of months as it enrolled a total of more than 8 million Americans. But it’s still a very dicey proposition for the thousands of corporate CEOs and owners of SME businesses across the country that are still anticipating, calibrating, leveraging and countering its effects.

Read More »

Overcoming Executive and Worker Pay Issues

The issues of “equal pay” and “just compensation” are hitting CEOs and business owners at every level, fed by an anxiety-producing brew of “inequality” politics, “living-wage” considerations and gender jealousies that has boiled over into an increasingly urgent matter demanding the attention of upper management.

Read More »

BlueGrace’s Social Media Ambassadors

More companies are turning to the true last frontier of social-media use in business: allowing employees to leverage social media on behalf of the company. BlueGrace Logistics, for instance, encourages all 160 staffers at its $150-million Riverview, Florida-based company to use LinkedIn, Facebook, Twitter and other social media to talk about the company and its services and to mingle such ...

Read More »

Pfizer Lets Loose a Hornets’ Nest Over U.S. Corporate Tax Rates

Pfizer is bidding to acquire AstraZeneca in large part so that it can dodge the U.S. corporate tax rate of 35 percent by shifting its corporate headquarters to the UK, AstraZeneca’s home, after the acquisition and paying that country’s 20-percent rate. But in pursuing the merger, Pfizer has kicked a political and economic hornets’ nest that still hasn’t emptied.

Read More »